We hypothesize that the upregulation of NMDAR interactors, such as Dlg3, Myh10, Ppp3a, Psen1, and Dnm1, may contribute to the anti-epilepsy phenotype by keeping the activity of NMDARs in control. Here, DNM1 is linked to epilepsy.